Nomenclature for factors of the HLA system, 2010.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

279 citing papers in PubMed, 3 syntheses or guidelines pooled it.

1. The role of human leukocyte antigen in HTLV-1 infection and progression to ATLL and HAM/TSP: a systematic review and meta-analysis.Virology journal · 2025
   Pooled it
2. Selection of unrelated donors and cord blood units for hematopoietic cell transplantation: guidelines from the NMDP/CIBMTR.Blood · 2019
   Guideline
3. Do HLA class II genes protect against pulmonary tuberculosis? A systematic review and meta-analysis.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2016
   Pooled it
4. Identifying the HLA DRB1-DQB1 molecules and predicting epitopes associated with high-risk HPV infection clearance and redetection.Scientific reports · 2020
   Trial
5. The Novel HLA-B*51:397 Allele, Identified by Sanger Dideoxy Nucleotide Sequencing in a Chinese Individual.HLA · 2026
   Article
6. Recommendations From the Implementation Steering Group for Organ Utilisation Histocompatibility and Immunogenetics Sub-Group: ISOU H&I Sub-Group Recommendations.International journal of immunogenetics · 2026
   Review
7. Identification of Two Novel HLA-DQB1 Alleles: HLA-DQB1*03:620 and HLA-DQB1*06:560.HLA · 2026
   Article
8. The Novel HLA-DQB1*04:97 Allele, Identified by Sanger Dideoxy Nucleotide Sequencing in a Chinese Individual.HLA · 2026
   Article
9. Full-Length Next-Generation Sequencing of 11 HLA Loci of More Than 1000 Individuals From Clinical Cohorts in East and West Africa.HLA · 2026
   Article
10. A Novel HLA Class I Allele, HLA-B*27:310, Identified Using Next-Generation Sequencing.HLA · 2026
    Article
11. Characterisation of the Novel HLA-C*03:02:18 Allele by Sequencing-Based Typing in a Taiwanese Individual.HLA · 2026
    Article
12. Characterisation of the Novel HLA-B*07:05:15 Allele by Sequencing-Based Typing.HLA · 2026
    Article
13. Allelic variation alters expression and antigen presentation of MR1 allomorphs.The Journal of biological chemistry · 2026
    Article
14. FuFiHLA: a tool for full-field HLA typing from long-read data.Bioinformatics (Oxford, England) · 2026
    Article
15. HLA-A*02:1227 and HLA-A*36:16N, Two Novel HLA-A Alleles Identified in Brazilian Bone Marrow Donors.HLA · 2026
    Article
16. The Phenotype List String Grammar for Enhanced Protein and Antigen Reporting in the Immunogenetic Context.HLA · 2026
    Article
17. Four Novel HLA-B and HLA-C Alleles Identified in Brazilian Individuals.HLA · 2026
    Article
18. The Novel HLA Class II Alleles DRB1*15:03:06, DQB1*03:01:69 and DPB1*04:01:95 Identified in Brazilian Donors.HLA · 2026
    Article
19. Nomenclature for Factors of the HLA System, 2026.HLA · 2026
    Article
20. Association between Human Leukocyte Antigen Alleles and Neuropathological Outcomes in Lewy Body Disease.Annals of neurology · 2026
    Article

219 more citing papers are in PubMed but not listed here.

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

Authors and funding

24 authors.

Funding

Abstract

PubMed holds no abstract for this paper.

Indexed as